YHB Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.6M Buy
48,988
+1,182
+2% +$567K 1.57% 13
2026
Q1
$23.5M Buy
47,806
+40
+0.1% +$21.7K 1.68% 11
2025
Q4
$27.7M Buy
47,766
+843
+2% +$477K 1.91% 11
2025
Q3
$22.8M Sell
46,923
-241
-0.5% -$112K 1.66% 11
2025
Q2
$19.1M Buy
47,164
+581
+1% +$243K 1.48% 13
2025
Q1
$23.2M Buy
46,583
+133
+0.3% +$72K 1.94% 10
2024
Q4
$24.2M Buy
46,450
+200
+0.4% +$110K 1.99% 11
2024
Q3
$28.6M Sell
46,250
-439
-0.9% -$260K 2.37% 7
2024
Q2
$25.8M Sell
46,689
-299
-0.6% -$171K 2.22% 10
2024
Q1
$27.3M Sell
46,988
-863
-2% -$484K 2.42% 7
2023
Q4
$25.4M Sell
47,851
-2,808
-6% -$1.36M 2.46% 6
2023
Q3
$25.6M Sell
50,659
-323
-0.6% -$172K 2.37% 7
2023
Q2
$26.6M Sell
50,982
-490
-1% -$264K 2.48% 6
2023
Q1
$29.7M Sell
51,472
-306
-0.6% -$172K 2.97% 3
2022
Q4
$28.5M Sell
51,778
-1,662
-3% -$881K 3.04% 3
2022
Q3
$27.1M Sell
53,440
-205
-0.4% -$115K 3.01% 4
2022
Q2
$29.1M Sell
53,645
-418
-0.8% -$230K 3.07% 3
2022
Q1
$31.9M Sell
54,063
-1,845
-3% -$1.06M 2.82% 4
2021
Q4
$37.3M Sell
55,908
-327
-0.6% -$204K 2.96% 4
2021
Q3
$32.1M Sell
56,235
-674
-1% -$370K 2.77% 4
2021
Q2
$28.7M Sell
56,909
-199
-0.3% -$93.9K 2.45% 4
2021
Q1
$28.1M Sell
57,108
-533
-0.9% -$254K 2.44% 5
2020
Q4
$26.8M Sell
57,641
-559
-1% -$262K 2.56% 5
2020
Q3
$25.7M Sell
58,200
-12,884
-18% -$5.32M 2.79% 5
2020
Q2
$25.8M Sell
71,084
-1,092
-2% -$366K 3.72% 3
2020
Q1
$20.5M Sell
72,176
-752
-1% -$237K 3.53% 3
2019
Q4
$23.7M Sell
72,928
-2,660
-4% -$807K 3.38% 3
2019
Q3
$22M Buy
75,588
+1,494
+2% +$428K 3.36% 3
2019
Q2
$21.8M Sell
74,094
-1,985
-3% -$547K 3.46% 3
2019
Q1
$20.8M Sell
76,079
-835
-1% -$208K 3.26% 3
2018
Q4
$17.2M Sell
76,914
-21,167
-22% -$4.97M 3.08% 4
2018
Q3
$23.9M Sell
98,081
-1,412
-1% -$325K 3.61% 3
2018
Q2
$20.6M Buy
99,493
+389
+0.4% +$82.6K 3.37% 3
2018
Q1
$20.5M Buy
99,104
+731
+0.7% +$153K 3.47% 4
2017
Q4
$18.7M Buy
98,373
+200
+0.2% +$38.3K 3.18% 4
2017
Q3
$18.6M Buy
98,173
+4,133
+4% +$749K 3.32% 3
2017
Q2
$16.4M Sell
94,040
-4,704
-5% -$790K 2.82% 5
2017
Q1
$16.3M Buy
98,744
+760
+0.8% +$116K 3.13% 4
2016
Q4
$13.8M Buy
97,984
+16,867
+21% +$2.49M 2.88% 4
2016
Q3
$12.9M Sell
81,117
-15,911
-16% -$2.45M 3.11% 2
2016
Q2
$14.3M Buy
97,028
+17,920
+23% +$2.64M 3.15% 2
2016
Q1
$11.2M Sell
79,108
-17,740
-18% -$2.38M 3.02% 2
2015
Q4
$13.7M Buy
96,848
+686
+0.7% +$91.5K 3.11% 1
2015
Q3
$11.8M Buy
96,162
+942
+1% +$123K 2.78% 5
2015
Q2
$12.4M Buy
95,220
+2,106
+2% +$275K 2.7% 4
2015
Q1
$12.5M Buy
93,114
+740
+0.8% +$95.4K 2.81% 3
2014
Q4
$11.6M Buy
92,374
+2,683
+3% +$326K 2.65% 6
2014
Q3
$10.9M Buy
89,691
+1,235
+1% +$150K 2.62% 6
2014
Q2
$10.4M Buy
88,456
+1,094
+1% +$129K 2.52% 8
2014
Q1
$10.5M Buy
87,362
+4,070
+5% +$484K 2.67% 5
2013
Q4
$9.28M Buy
83,292
+737
+0.9% +$73.3K 2.49% 7
2013
Q3
$7.61M Sell
82,555
-1,545
-2% -$140K 2.25% 9
2013
Q2
$7.12M Buy
+84,100
New +$7M 2.22% 6

Other funds holding TMO

YHB Investment Advisors's TMO Position: Q2 2026 in Review

YHB Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 2.5% in Q2 2026, buying an estimated $567K and bringing the position to 48,988 shares worth $24.6M. The position accounts for 1.57% of the portfolio, ranked #13.

YHB Investment Advisors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $37.3M in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • YHB Investment Advisors held 48,988 shares of Thermo Fisher Scientific worth $24.6M as of Q2 2026.
  • YHB Investment Advisors bought 1,182 Thermo Fisher Scientific shares in Q2 2026, an estimated $567K.
  • Thermo Fisher Scientific made up 1.57% of YHB Investment Advisors's portfolio in Q2 2026, its #13 holding.
  • YHB Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • YHB Investment Advisors's Thermo Fisher Scientific position peaked at $37.3M in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.